Misplaced Pages

The examples and perspective in this article deal primarily with the United States and do not represent a worldwide view of the subject. You may improve this article, discuss the issue on the talk page, or create a new article, as appropriate. (May 2018) (Learn how and when to remove this message)

Unnecessary health care (overutilization, overuse, or overtreatment) is health care provided with a higher volume or cost than is appropriate. In the United States, where health care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its health care spending ($750 billion out of $2.6 trillion) in 2012.

Factors that drive overuse include paying health professionals more to do more (fee-for-service), defensive medicine to protect against litigiousness, and insulation from price sensitivity in instances where the consumer is not the payer—the patient receives goods and services but insurance pays for them (whether public insurance, private, or both). Such factors leave many actors in the system (doctors, patients, pharmaceutical companies, device manufacturers) with inadequate incentive to restrain health care prices or overuse. This drives payers, such as national health insurance systems or the U.S. Centers for Medicare and Medicaid Services, to focus on medical necessity as a condition for payment. However, the threshold between necessity and lack thereof can often be subjective.

Overtreatment, in the strict sense, may refer to unnecessary medical interventions, including treatment of a self-limited condition (overdiagnosis) or to extensive treatment for a condition that requires only limited treatment.

It is economically linked with overmedicalization.

Definition

A forerunner of the term was what Jack Wennberg called unwarranted variation, different rates of treatments based upon where people lived, not clinical rationale. He had discovered that in studies that began in 1967 and were published in the 1970s and the 1980s: "The basic premise – that medicine was driven by science and by physicians capable of making clinical decisions based on well-established fact and theory – was simply incompatible with the data we saw. It was immediately apparent that suppliers were more important in driving demand than had been previously realized."

In 2008, US bioethicist Ezekiel J. Emanuel and health economist Victor R. Fuchs defined unnecessary health care as "overutilization", health care provided with a higher volume or cost than is appropriate. Recently, economists have sought to understand unnecessary health care in terms of misconsumption rather than overconsumption.

In 2009 two US physicians wrote in an editorial, that unnecessary care was "defined as services which show no demonstrable benefit to patients" and might represent 30% of U.S. medical care. They referred to a 2003 study on regional variations in Medicare spending, which found, "Medicare enrollees in higher-spending regions receive more care than those in lower-spending regions, but do not have better health outcomes or satisfaction with care."

In January 2012, the American College of Physicians Ethics, Professionalism, and Human Rights Committee suggested that overtreatment can also be understood in contrast to 'parsimonious care', defined as "care that utilizes the most efficient means to effectively diagnose a condition and treat a patient."

In April 2012, Berwick, from the Institute for Healthcare Improvement, and Andrew Hackbarth from the RAND Corporation defined overtreatment as "subjecting patients to care that, according to sound science and the patients' own preferences, cannot possibly help them—care rooted in outmoded habits, supply-driven behaviors, and ignoring science." They wrote that trying to do something (treatment or testing) for all patients who might need it inevitably entails doing that same thing for some patients who might not need it." In uncertain situations, "some non-beneficial care was the necessary byproduct of optimal clinical decision making."

In October 2015, two pediatricians said that considering "overtreatment as an ethical violation" could help see the conflicting incentives of health care workers for treatment or nontreatment.

Low-value health care, for the most part, is administration of tests or treatment, which though useful initially, offer little value if given repeatedly as a part of routine care.

Cost

In the US, the country which spends the most on health care per person globally, patients have fewer doctor visits and fewer days in hospitals than people in other countries do, but prices are high, there is more use of some procedures and new drugs than elsewhere, and doctor salaries are double the levels in other countries. The New York Times reported "no one knows for sure" how much unnecessary care exists in the United States. Overuse of medical care is no longer a large fraction of total health care spending, which was $3.3 trillion in 2016.

Researchers in 2014 analyzed many services listed as low value by Choosing Wisely and other sources. They looked at spending in 2008–2009 and found that these services represented 0.6% or 2.7% of Medicare costs and there was no significant pattern of particular types of physicians ordering these low value services. The Institute of Medicine in 2010 gave two estimates of "unnecessary services," using different methodologies: 0.2% or 1% to 5% of health spending, which was US$2.6 trillion. The Institute of Medicine quoted that 2010 report in a 2012 report to support an estimate of 8% ($210 billion) in unnecessary services, without explaining the discrepancy. This IOM 2012 report also said there were $555 billion in other wasted spending, which have an "unknown overlap" with each other and the $210 billion. The United States National Academy of Sciences estimated in 2005, without giving its methods or sources, that "between $.30 and $.40 of every dollar spent on health care is spent on the costs of poor quality," amounting to" slightly more than a half-trillion dollars a year... wasted on overuse, underuse, misuse, duplication, system failures, unnecessary repetition, poor communication, and inefficiency. In 2003 Fisher et al. found that there was "no apparent regional health benefit for Medicare recipients from doing more, whether 'more' is expressed as hospitalizations, surgical procedures, or consultations within the hospital." Up to 30% of Medicare spending could be cut in 2003 without harming patients.

A study of low-value care in laboratory testing suggested that Medicare may have overspent at least US$1.95 billion on laboratory tests in the year 2019. The study found excessively frequent ordering of Hemoglobin A1c, prostate-specific antigen, vitamin D 25-hydroxy, and lipid panels.

When care is overused, patients are put at risk of complications unnecessarily, with documented harm to patients from overuse of surgeries and other treatments.

Causes

Physicians' decisions are the proximate cause of unnecessary care, though the potential incentives and penalties they face can influence their choices.

Third-party payers and fee-for-service

When public or private insurance cover expenses and doctors are paid under a fee-for-service (FFS) model, neither has an incentive to consider the cost of treatment, a combination that contributes to waste. Fee-for-service is a large incentive for overuse because health care providers (such as doctors and hospitals) receive revenue from the overtreatment.

Atul Gawande investigated Medicare FFS reimbursements in McAllen, Texas, for a 2009 article in the New Yorker. In 2006, the town of McAllen was the second-most expensive Medicare market, behind Miami. Costs per beneficiary were almost twice the national average.

In 1992, however, McAllen had been almost exactly in line with the Medicare spending average. After looking at other potential explanations such as relatively poorer health or medical malpractice, Gawande concluded the town was a chief example of the overuse of medical services. Gawande concluded that a business culture (physicians viewing their practices as a revenue stream) had established itself there, in contrast to a culture of low-cost high-quality medicine at the Mayo Clinic and in the Grand Junction, Colorado, market. Gawande advised:

As America struggles to extend healthcare coverage while curbing health care costs, we face a decision that is more important than whether we have a public-insurance option, more important than whether we will have a single-payer system in the long run or a mixture of public and private insurance, as we do now. The decision is whether we are going to reward the leaders who are trying to build a new generation of Mayos and Grand Junctions. If we don't, McAllen won't be an outlier. It will be our future.

Medical malpractice laws and defensive medicine

To protect themselves from legal prosecution U.S. physicians have an incentive to order clinically unnecessary tests or tests of little potential value. While defensive medicine is a favored explanation for high medical costs by physicians, Gawande estimated in 2010 it only contributed to 2.4% of the total $2.3 trillion of U.S. health care spending in 2008.

Direct-to-consumer advertising

Direct-to-consumer advertising can encourage patients to ask for drugs, devices, diagnostics, or procedures. Sometimes service providers will simply give these treatments or services rather than attempting the potentially more unpleasant task of convincing the patient what they have requested is not needed, or is likely to cause more harm than good.

Physician predispositions

Dartmouth Medical School professor Gilbert Welch argued 2016 that certain predispositions by physicians and the general public may lead to unnecessary health care, including:

• Attempting to mitigate a risk without considering how small or unlikely the potential benefit is
• Attempting to fix an underlying problem, instead of using a less-risky monitoring or coping strategy
• Acting too quickly, when waiting for more information might be wiser
• Acting without considering the benefits of doing nothing
• Discounting downsides of diagnostic testing
• Preferring newer over older treatments without considering the cost of new treatments or the effectiveness of older ones
• Treating patients with terminal illness to maximize life span over quality of life, without probing a patient's preferences

Examples

Imaging

Overuse of diagnostic imaging, such as X-rays and CT scans, is defined as any application unlikely to improve patient care. Factors that contribute to overuse include "self-referral, patient wishes, inappropriate financially motivated factors, health system factors, industry, media, lack of awareness" and defensive medicine. Respected organizations—such as the American College of Radiology (ACR), Royal College of Radiologists (RCR) and the World Health Organization (WHO)—have developed "appropriateness criteria". The Canadian Association of Radiologists estimated in 2009 that 30% of imaging was unnecessary in the Canadian health care system. 2008 Medicare claims showed overuse with chest CT's. Financial incentives have also been shown to have a significant impact on dental X-ray use with dentists who are paid a separate fee for each X-ray providing more X-rays.

Overuse of imaging can lead to a diagnosis of a condition that would have otherwise remained irrelevant (overdiagnosis).

Physician self-referral

One type of overuse can be physician self-referral. Multiple studies have replicated the finding that when non-radiologists have an ownership interest in the fees generated by radiology equipment—and can self-refer—their use of imaging is unnecessarily higher. The majority of U.S. growth in imaging use (the fastest-growing physician service) comes from self-referring nonradiologists. In 2004, this overuse was estimated to contribute to $16 billion of annual U.S. health care costs.

As of a 2018 review evidence of overtreatment overmedicalization, and overdiagnosis in Pediatrics have been use of commercial rehydration solution, antidepressants, and parenteral nutrition; overmedicalization with planned early deliveries, immobilization of ankle injuries, use of hydrolyzed infant formula; and overdiagnosis of hypoxemia among children recovering from bronchiolitis.

Others

• Hospitalizations for those with chronic conditions who could be treated as outpatients
• Surgeries in Medicare patients in their last year of life; regions with high levels had higher death rates
• Antibiotic use for viral or self-limiting infections (an overmedication that can promote antibiotic resistance)
• Opiate prescriptions carry the risk of addiction. In some cases, the number of pills prescribed might exceed what is actually needed for pain relief from a given condition, or a different pain management technique or medication would be effective but less risky.
• Many blood transfusions in the U.S. are given without checking to see if they are needed after a previous transfusion, or are given in cases where monitoring, recovering the patient's own blood, or iron therapy would be effective and reduce the risk of complications
• An estimated one in eight coronary stents (used in $20,000 procedures) with nonacute indications (U.S.)
  • Stents performed by the formal chair of cardiology, Mark Midei, at St. Joseph Medical Center of Towson, Maryland
• Heart bypass surgeries at Redding Medical Center which resulted in an FBI raid
• Screening patients with advanced cancer for other cancers
• Annual cervical cancer screening in women with medical histories of normal pap smear and HPV test results

Reduction efforts

Utilization management (utilization review) has evolved over decades among both public and private payers in an attempt to reduce overuse. In this effort, insurers employ physicians to review the actions of other physicians and detect overuse. Utilization review has a poor reputation among most clinicians as a corrupted system in which utilization reviewers have their own perverse incentives (i.e., find ways to deny coverage no matter what) and in some cases are not practicing physicians, lacking real-world clinical insight or wisdom. Results of a recent systematic review found that many studies focused more on reductions in utilization than in improving clinically meaningful measures.

The 2010 U.S. health care reform, the Patient Protection and Affordable Care Act, did not contain serious strategies to reduce overuse; "the public has made it clear that it does not want to be told what medical care it can and cannot have." Uwe Reinhardt, a health economist at Princeton, said "the minute you attack overutilization, you will be called a Nazi before the day is out".

Professional societies and other groups have begun to push for policy changes that would encourage clinicians to avoid providing unnecessary care. Most physicians accept that laboratory tests are overused, but "it remains difficult to persuade them to consider the possibility that they, too, might be overutilizing laboratory tests." In November 2011, the American Board of Internal Medicine Foundation began the Choosing Wisely campaign, which aims to raise awareness of overtreatment and change physician behavior by publicizing lists of tests and treatments that are often overused, and which doctors and patients should try to avoid.

The Clinical and Laboratory Standards Institute (CLSI) issued a 2017 guideline, "Developing and Managing a Medical Laboratory (Test) Utilization Program (GP49)", to help laboratories establish stewardship programs.

Clinical decision support tools can help decrease unnecessary laboratory testing. The PLUGS initiative (Patient-Centered Laboratory Utilization Guidance Services) aims to formalize laboratory stewardship practices. The TRUU-Lab (Test Renaming for Understanding and Utilization in the Laboratory) initiative is a cooperative effort of CDC, CMS, FDA, and CAP. The project aims to standardize the names of laboratory tests to limit errant test ordering. Genetic testing stewardship programs have been established to streamline molecular diagnostic ordering patterns.

The Joint Commission offers accreditation in patient blood management in conjunction with AABB. To become accredited, participating hospitals may distribute guidelines for appropriateness of blood transfusion, form a committee to audit blood utilization, identify areas for improvement, and monitor compliance.

In the UK, 2011, online platform AskMyGP was launched to decrease the amount of unnecessary medical appointments. In the app patients are given a questionnaire about their symptoms, which then assesses the patient's need for medical care. The program was a success, and as of January 2018 has managed over 29,000 patient episodes.

The Royal College of Pathologists issued 2021 guidelines for the minimum time that should elapse before a given laboratory test is repeated in a specific clinical scenario.

In April 2012, the Lown Institute and the New America Foundation Health Policy Program convened the 'Avoiding Avoidable Care' conference. It was the first major medical conference to focus entirely on overuse, and it included presentations from speakers including Bernard Lown, Don Berwick, Christine Cassel, Amitabh Chandra, JudyAnn Bigby, and Julio Frenk. A second meeting was planned for December 2013.

Since the meeting, the Lown Institute has focused its work on deepening the understanding of overuse and generating public discussion of the ethical and cultural drivers of overuse, especially on the role of the hidden curriculum in medical school and residency.

Patient safety committees, which are charged with reviewing the quality of care, can view overutilization as adverse event.

Consumer cost sharing

This section needs expansion. You can help by adding to it. (October 2011)

See also

• Medicare fraud
• Moral hazard
• Antibiotic misuse
• Antibiotic stewardship
• Choosing Wisely
• Clinical decision support
• Overmedicalization
• Overdiagnosis
• Patient blood management

References

Citations

1. ^ Ezekiel J. Emanuel, Victor R. Fuchs (2008). "The perfect storm of overutilization" (PDF). The Journal of the American Medical Association. 299 (23): 2789–91. doi:10.1001/jama.299.23.2789. PMID 18560006. Archived from the original (PDF) on September 2, 2009.
2. Kliff, Sarah (September 7, 2012). "We spend $750 billion on unnecessary health care. Two charts explain why". The Washington Post. Archived from the original on December 30, 2015. Retrieved March 31, 2016.
3. Ezekiel J. Emanuel & Victor R. Fuchs (2008). "Health Care Overutilization in the United States—Reply". The Journal of the American Medical Association. 300 (19): 2251. doi:10.1001/jama.2008.605.
4. ^ Victor R. Fuchs (December 2009). "Eliminating 'waste' in health care". JAMA: The Journal of the American Medical Association. 302 (22): 2481–2482. doi:10.1001/jama.2009.1821. PMID 19996406.
5. Alix Spiegel (November 10, 2009). "More is Less". This American Life. Archived from the original on November 5, 2011.
6. Michael T. McCue Clamping down on variation Archived December 18, 2007, at the Wayback Machine – Managed Healthcare Executive, February 01, 2003
7. Hensher, Martin; Tisdell, John; Zimitat, Craig (March 1, 2017). ""Too much medicine": Insights and explanations from economic theory and research" (PDF). Social Science & Medicine. 176: 77–84. doi:10.1016/j.socscimed.2017.01.020. PMID 28131024.
8. Reilly BM, Evans AT (2009). "Much ado about (doing) nothing". Ann Intern Med. 150 (4): 270–1. CiteSeerX 10.1.1.688.1277. doi:10.7326/0003-4819-150-4-200902170-00008. PMID 19221379. S2CID 12934288. (subscription required)
9. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL (February 2003). "The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care". Ann. Intern. Med. 138 (4): 288–98. doi:10.7326/0003-4819-138-4-200302180-00007. PMID 12585826. S2CID 8031637.{{cite journal}}: CS1 maint: multiple names: authors list (link)
10. Snyder L (2012). "American College of Physicians Ethics Manual: sixth edition". Ann Intern Med. 156 (1 Pt 2): 73–104. doi:10.7326/0003-4819-156-1-201201031-00001. PMID 22213573. S2CID 207536403.
11. Berwick DM, Hackbarth AD (April 2012). "Eliminating waste in US health care". JAMA. 307 (14): 1513–6. doi:10.1001/jama.2012.362. PMID 22419800.
12. Ralston Shawn L., Schroeder Alan R. (2015). "Doing More vs Doing Good: Aligning Our Ethical Principles From the Personal to the Societal". JAMA Pediatrics. 169 (12): 1085–6. doi:10.1001/jamapediatrics.2015.2702. PMID 26502277. (subscription required)
13. American Heart Association Council on Quality of Care and Outcomes Research (February 22, 2022). "Strategies to Reduce Low-Value Cardiovascular Care: A Scientific Statement From the American Heart Association". Circulation: Cardiovascular Quality and Outcomes. 15 (3): HCQ0000000000000105. doi:10.1161/HCQ.0000000000000105. PMC 9909614. PMID 35189687. S2CID 247023707.
14. Kliff, Sarah (October 16, 2017). "The problem is the prices". Retrieved December 7, 2018.
15. Squires, David; Anderson, Chloe (2015). "Spending, Use of Services, Prices, and Health in 13 Countries". commonwealthfund.org. doi:10.26099/77tf-5060. Retrieved December 7, 2018.
16. ^ Gina Colata (March 29, 2010). "Law May Do Little to Help Curb Unnecessary Care". The New York Times. Archived from the original on July 16, 2017.
17. ^ "Table 1 National Health Expenditures". cms.gov. Retrieved December 5, 2018.
18. McWilliams, J. Michael; Chernew, Michael E.; Elshaug, Adam G.; Landon, Bruce E.; Schwartz, Aaron L. (July 1, 2014). "Measuring Low-Value Care in Medicare". JAMA Internal Medicine. 174 (7): 1067–1076. doi:10.1001/jamainternmed.2014.1541. ISSN 2168-6106. PMC 4241845. PMID 24819824.
19. McWilliams, J. Michael; Zaslavsky, Alan M.; Jena, Anupam B.; Schwartz, Aaron L. (December 3, 2018). "Analysis of Physician Variation in Provision of Low-Value Services". JAMA Internal Medicine. 179 (1): 16–25. doi:10.1001/jamainternmed.2018.5086. PMC 6583417. PMID 30508010.
20. Institute of Medicine (2010). The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary. doi:10.17226/12750. ISBN 978-0-309-14433-9. PMID 21595114. Retrieved December 7, 2018. {{cite book}}: |website= ignored (help)
21. ^ Loukopoulos, T.; Ahmad, I. (2000). "Replicating the contents of a WWW multimedia repository to minimize download time". Proceedings 14th International Parallel and Distributed Processing Symposium. IPDPS 2000. The National Academies Press. pp. 101–102. doi:10.1109/ipdps.2000.846027. ISBN 978-0-309-26073-2. S2CID 9998202.
22. Lawrence, David (2005). Building a Better Delivery System: A New Engineering/Health Care Partnership – Bridging the Quality Chasm. Washington, DC: National Academy of Sciences. p. 99. doi:10.17226/11378. ISBN 978-0-309-65406-7. PMID 20669457. Archived from the original on July 9, 2008.
23. Elliott S. Fisher, David E. Wennberg, Thérèse A. Stukel, Daniel J. Gottlieb, F. L. Lucas & Etoile L. Pinder (February 2003). "The implications of regional variations in Medicare spending. Part 1: the content, quality, and accessibility of care". Annals of Internal Medicine. 138 (4): 273–287. doi:10.7326/0003-4819-138-4-200302180-00006. PMID 12585825. S2CID 27581938.{{cite journal}}: CS1 maint: multiple names: authors list (link)
24. ^ Elliott S. Fisher, David E. Wennberg, Therese A. Stukel, Daniel J. Gottlieb, F. L. Lucas & Etoile L. Pinder (February 2003). "The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care". Annals of Internal Medicine. 138 (4): 288–298. doi:10.7326/0003-4819-138-4-200302180-00007. PMID 12585826. S2CID 8031637.{{cite journal}}: CS1 maint: multiple names: authors list (link)
25. ^ Steven A. Schroeder (April 2011). "Personal reflections on the high cost of American medical care: Many causes but few politically sustainable solutions". Archives of Internal Medicine. 171 (8): 722–727. doi:10.1001/archinternmed.2011.149. PMID 21518938.
26. Smart D, Schreier J, Singh IR (June 2024). "Inappropriate Laboratory Testing: Significant Waste Quantified by a Large-Scale Year-Long Study of Medicare and Commercial Payer Reimbursement". Arch Pathol Lab Med. doi:10.5858/arpa.2023-0486-OA. PMID 38839058.
27. "Medicare Options In Biden Budget Talks Get Boost". NPR. The Associated Press. June 15, 2011. Retrieved June 26, 2011.
28. Gibson; Singh, Rosemary (2010). The Treatment Trap: How the Overuse of Medical Care is Wrecking Your Health. Chicago: Ivan R. Dee. pp. 63–83. ISBN 9781566638425.
29. Katty Kay (July 7, 2009). "Texas town's healthcare puzzle". BBC News. Archived from the original on February 16, 2010. Retrieved June 19, 2011.
30. Bryant Furlow (October 2009). "US reimbursement systems encourage fraud and overutilisation". The Lancet Oncology. 10 (10): 937–938. doi:10.1016/S1470-2045(09)70297-9. PMID 19810157.
31. ^ Atul Gawande (June 1, 2009). "The Cost Conundrum – What a Texas town can teach us about health care". The New Yorker. Archived from the original on June 10, 2011. Retrieved June 29, 2011.
32. ^ "Spend More, Get Less? The Health Care 'Conundrum'". Fresh Air. NPR. June 17, 2009. Archived from the original on March 28, 2014. Retrieved June 29, 2011.
33. Michelle Mello, Amitabh Chandra, Atul A. Gawande & David M. Studdert (September 2010). "National costs of the medical liability system". Health Affairs. 29 (9): 1569–1577. doi:10.1377/hlthaff.2009.0807. PMC 3048809. PMID 20820010.{{cite journal}}: CS1 maint: multiple names: authors list (link)
34. Gilbert Welch Assumptions That Drive Too Much Medical Care American College of Physicians, n.d., retrieved 9 May 2018
35. Gilbert Welch (2016). Less Medicine, More Health. Beacon Press. ISBN 978-0807077580.
36. ^ B. Rehani (January 2011). "Imaging overutilisation: Is enough being done globally?". Biomedical Imaging and Intervention Journal. 7 (1): e6. doi:10.2349/biij.7.1.e6 (inactive November 1, 2024). PMC 3107688. PMID 21655115.{{cite journal}}: CS1 maint: DOI inactive as of November 2024 (link)
37. "Do you need that scan?" (PDF). Canadian Association of Radiologists. 2009. Archived from the original (PDF) on March 22, 2011. Retrieved June 27, 2011.
38. Walt Bogdanich; Jo Craven McGinty (June 17, 2011). "Medicare Claims Show Overuse for CT Scanning". The New York Times. Archived from the original on September 20, 2020. Retrieved June 22, 2011.
39. Chalkley, M.; Listl, S. (December 30, 2017). "First do no harm – The impact of financial incentives on dental X-rays" (PDF). Journal of Health Economics. 58 (March 2018): 1–9. doi:10.1016/j.jhealeco.2017.12.005. PMID 29408150. S2CID 46797965.
40. Elm Ho (July 2010). "Overuse, overdose, overdiagnosis... overreaction?". Biomedical Imaging and Intervention Journal. 6 (3): e8. doi:10.2349/biij.6.3.e8. PMC 3097773. PMID 21611049.
41. ^ David C. Levin & Vijay M. Rao (March 2004). "Turf wars in radiology: the overutilization of imaging resulting from self-referral". Journal of the American College of Radiology. 1 (3): 169–172. doi:10.1016/j.jacr.2003.12.009. PMID 17411553.
42. Coon Eric R., Young Paul C., Quinonez Ricardo A., Morgan Daniel J., Dhruva Sanket S., Schroeder Alan R. (2018). "2017 Update on Pediatric Medical Overuse". JAMA Pediatrics. 172 (5): 482–486. doi:10.1001/jamapediatrics.2017.5752. PMID 29582079. S2CID 4369253.{{cite journal}}: CS1 maint: multiple names: authors list (link)
43. James CD, Hanson K, Solon O, Whitty CJ, Peabody J (June 2011). "Do doctors under-provide, over-provide or do both? Exploring the quality of medical treatment in the Philippines". International Journal for Quality in Health Care. 23 (4): 445–55. doi:10.1093/intqhc/mzr029. PMC 3136200. PMID 21672923.
44. "Effective Care – A Dartmouth Atlas Project Topic Brief" (PDF). Dartmouth Atlas Project. January 15, 2007. Archived (PDF) from the original on October 2, 2011. Retrieved June 29, 2011.
45. Carrie Gann (October 6, 2011). "Medicare Patients Get Costly Surgery Before Death". ABC News. Retrieved October 6, 2011.
46. Kwok AC, Semel ME, Lipsitz SR, Bader AM, Barnato AE, Gawande AA, Jha AK (2011). "The intensity and variation of surgical care at the end of life: a retrospective cohort study". The Lancet. 378 (9800): 1408–1413. doi:10.1016/S0140-6736(11)61268-3. PMID 21982520. S2CID 31805773.
47. Malika Taufiq & Rukhsana W. Zuberi (January 2011). "Overuse of antibiotics in children for upper respiratory infections (URIs): a dilemma". Journal of the College of Physicians and Surgeons--Pakistan. 21 (1): 60. PMID 21276393.
48. Markus Dietl & Dieter Korczak (2011). "Over-, under- and misuse of pain treatment in Germany". GMS Health Technology Assessment. 7: Doc03. doi:10.3205/hta000094. PMC 3080661. PMID 21522485.
49. Ryan Jaslow (June 28, 2011) Blood transfusion regulations needed to rein in overuse: Panel CBS News/Associated Press. Accessed June 28, 2011.
50. Ron Winslow; John Carreyrou (July 6, 2011). "Heart Treatment Overused – Study Finds Doctors Often Too Quick to Try Costly Procedures to Clear Arteries". The Wall Street Journal. Archived from the original on July 17, 2015. Retrieved July 6, 2011.
51. Chan; et al. (2011). "Appropriateness of Percutaneous Coronary Intervention". JAMA. 306 (1): 53–61. doi:10.1001/jama.2011.916. PMC 3293218. PMID 21730241.
52. Jay Hancock (July 18, 2011). Progress, but not enough, against needless hospital procedures The Baltimore Sun Accessed August 4, 2011.
53. Final Decision and Order Archived September 30, 2011, at the Wayback Machine Maryland State Board of Physicians Accessed August 4, 2011.
54. Meredith Cohn (July 29, 2011). St. Joseph Medical Center's CEO resigns The Baltimore Sun Accessed August 4, 2011.
55. Larry Husten (July 13, 2011). Maryland Revokes Mark Midei’s Medical License Archived July 16, 2011, at the Wayback Machine Forbes Accessed August 4, 2011.
56. Walshe K, Shortell SM (2004). "When things go wrong: how health care organizations deal with major failures". Health Aff (Millwood). 23 (3): 103–11. doi:10.1377/hlthaff.23.3.103. PMID 15160808.
57. Gilbert M. Gaul (July 25, 2005). "At California Hospital, Red Flags and an FBI Raid". The Washington Post. Archived from the original on November 10, 2012. Retrieved July 5, 2011.
58. Rosemary Gibson (August 25, 2010). "Can Funders Quell a 'Perfect Storm of Overutilization'?". Health Affairs. doi:10.1377/forefront.20100825.006700.
59. Camelia S. Sima; Katherine S. Panageas; Deborah Schrag (October 2010). "Cancer screening among patients with advanced cancer". JAMA. 304 (14): 1584–1591. doi:10.1001/jama.2010.1449. PMC 3728828. PMID 20940384.
60. Roland KB, Soman A, Bernard VB, et al. (2011). "Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States". American Journal of Obstetrics and Gynecology. 205 (5): 447.e1–8. doi:10.1016/j.ajog.2011.06.001. PMID 21840492.
61. Kathleen Doheny (August 20, 2011). "Annual Pap tests often ordered but unneeded Archived March 20, 2012, at the Wayback Machine" HealthDay (USA Today). Accessed August 22, 2011.
62. Berenson, Robert A.; Docteur, Elizabeth (January 2013). "Doing Better by Doing Less: Approaches to Tackle Overuse of Services" (PDF). Urban Institute.
63. Maratt, Jennifer K.; Kerr, Eve A.; Klamerus, Mandi L.; Lohman, Shannon E.; Froehlich, Whit; Bhatia, R. Sacha; Saini, Sameer D. (2019). "Measures Used to Assess the Impact of Interventions to Reduce Low-Value Care: a Systematic Review". Journal of General Internal Medicine. 34 (9): 1857–1864. doi:10.1007/s11606-019-05069-5. ISSN 0884-8734. PMC 6712188. PMID 31250366.
64. Jamie A. Weydert, Newell D. Nobbs, Ronald Feld & John D. Kemp (September 2005). "A simple, focused, computerized query to detect overutilization of laboratory tests". Archives of Pathology & Laboratory Medicine. 129 (9): 1141–1143. doi:10.5858/2005-129-1141-ASFCQT. PMID 16119987.{{cite journal}}: CS1 maint: multiple names: authors list (link)
65. Cassel, Christine. K. (of Choosing Wisely); Guest, James A. (of Consumer Reports) (2012). "Choosing Wisely - Helping Physicians and Patients Make Smart Decisions About Their Care". The Journal of the American Medical Association. 307 (17): 1801–1802. doi:10.1001/jama.2012.476. PMID 22492759.
66. "New Test Utilization Document". clsi.gov. Clinical and Laboratory Standards Institute. July 31, 2017. Retrieved September 18, 2024.
67. Lewandrowski K (June 2019). "Integrating Decision Support into a Laboratory Utilization Management Program". Clin Lab Med. 39 (2): 245–257. doi:10.1016/j.cll.2019.01.004. PMID 31036278.
68. Dickerson JA, Fletcher AH, Procop G, Keren DF, Singh IR, Garcia JJ, Carpenter RB, Miles J, Jackson B, Astion ML (September 2017). "Transforming Laboratory Utilization Review into Laboratory Stewardship: Guidelines by the PLUGS National Committee for Laboratory Stewardship". J Appl Lab Med. 2 (2): 259–268. doi:10.1373/jalm.2017.023606. PMID 32630981.
69. Singh, Ila. "Standardizing Lab Test Names: the TRUU-Lab Initiative" (PDF). cdc.gov. CDC. Retrieved September 18, 2024.
70. "Creating a Universal Standard for Lab Test Names". Children's Hospital Association. March 1, 2024. Retrieved September 18, 2024.
71. Thomas M, Amlie-Wolf L, Baker L, Gripp KW (December 2021). "The Genetic Testing Stewardship Program:: A Bridge to Precision Diagnostics for the Non-genetics Medical Provider". Dela J Public Health. 7 (5): 20–23. doi:10.32481/djph.2021.12.007. PMC 9124555. PMID 35619979.
72. Gammon RR, Blanton K, Gilstad C, Hong H, Nichols T, Putnam H, Marinaro L, Segura T, Tay S, Bocquet C (August 2022). "How do we obtain and maintain patient blood management certification?". Transfusion. 62 (8): 1483–1494. doi:10.1111/trf.16929. PMID 35616174.
73. Lang, Dr. Tim; Croal, Dr. Bernie (March 2021). "National minimum retesting intervals in pathology (G147)" (PDF). Royal College of Pathologists. Retrieved September 19, 2024.
74. "Avoiding Avoidable Care". avoidablecare.org. Archived from the original on January 3, 2015. Retrieved January 19, 2015.
75. "Avoiding Avoidable Care Conference- Featured Speakers". Avoiding Avoidable Care. April 25–26, 2012. Archived from the original on August 14, 2013. Retrieved August 21, 2013.
76. "2013 Lown Conference: From Avoidable Care to Right Care". Lown Institute. Archived from the original on November 4, 2013. Retrieved August 21, 2013.
77. Zapata Josué A., Lai Andrew R., Moriates Christopher (2017). "Is Excessive Resource Utilization an Adverse Event?". JAMA. 317 (8): 849–850. doi:10.1001/jama.2017.0698. PMID 28245327.{{cite journal}}: CS1 maint: multiple names: authors list (link)

Sources

• Brownlee, Shannon (2007). Overtreated: Why too much medicine is making us sicker and poorer. London: Bloomsbury. ISBN 978-1-58234-580-2.
• Gawande, Atul (May 11, 2015). "America's Epidemic of Unnecessary Care". newyorker.com. Retrieved May 4, 2015.
• Hendee WR, Becker GJ, Borgstede JP, et al. (October 2010). "Addressing overutilization in medical imaging". Radiology. 257 (1): 240–5. doi:10.1148/radiol.10100063. PMID 20736333.
• R. E. Malone (October 1998). "Whither the almshouse? Overutilization and the role of the emergency department". Journal of Health Politics, Policy and Law. 23 (5): 795–832. doi:10.1215/03616878-23-5-795. PMID 9803363. S2CID 10081763.
• Sana M. Al-Khatib, Anne Hellkamp, Jeptha Curtis, Daniel Mark, Eric Peterson, Gillian D. Sanders, Paul A. Heidenreich, Adrian F. Hernandez, Lesley H. Curtis & Stephen Hammill (January 2011). "Non-evidence-based ICD implantations in the United States". JAMA: The Journal of the American Medical Association. 305 (1): 43–49. doi:10.1001/jama.2010.1915. PMC 3432303. PMID 21205965.{{cite journal}}: CS1 maint: multiple names: authors list (link)
• David B. Larson, Lara W. Johnson, Beverly M. Schnell, Shelia R. Salisbury & Howard P. Forman (January 2011). "National trends in CT use in the emergency department: 1995–2007". Radiology. 258 (1): 164–173. doi:10.1148/radiol.10100640. PMID 21115875.{{cite journal}}: CS1 maint: multiple names: authors list (link) – a story on the study
• Gawande, Atul A.; Colla, Carrie H.; Halpern, Scott D.; Landon, Bruce E. (April 3, 2014). "Avoiding Low-Value Care". New England Journal of Medicine. 370 (14): e21. doi:10.1056/NEJMp1401245. PMID 24693918.

External links

• "Disease Creep: How we're fooled into using more medicine than we need" by medical investigative journalist Jeanne Lenzer

• Unnecessary health care
• Health economics